Next Steps For Bayer’s Essure Device Coming In February, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
FDA will publicly announce actions it will take on Bayer’s Essure permanent birth control device at the end of February 2016 following its full review of the medical literature, adverse events reports, and input received during and after a September 24 advisory panel meeting on Essure, the agency said in a posting on its website.